Variant report
Variant | esv3411818 |
---|---|
Chromosome Location | chr7:136962062-136964060 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541560903 | chr7:136962064-136962065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs188915 | chr7:136962095-136962096 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs183362308 | chr7:136962183-136962184 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148600256 | chr7:136962198-136962199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188361950 | chr7:136962242-136962243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191162082 | chr7:136962243-136962244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1669045 | chr7:136962251-136962252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182440205 | chr7:136962261-136962262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73163685 | chr7:136962273-136962274 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs374030121 | chr7:136962293-136962294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142981133 | chr7:136962297-136962298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28578609 | chr7:136962328-136962329 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs543625629 | chr7:136962329-136962330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550132964 | chr7:136962359-136962360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs113374617 | chr7:136962361-136962362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs117112690 | chr7:136962460-136962461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551936999 | chr7:136962467-136962468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376895605 | chr7:136962495-136962496 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186622408 | chr7:136962589-136962590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192591433 | chr7:136962610-136962611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs71814853 | chr7:136962644-136962645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs202086206 | chr7:136962648-136962649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs67432231 | chr7:136962650-136962651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201457406 | chr7:136962651-136962652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs111269993 | chr7:136962652-136962653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370468437 | chr7:136962659-136962660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374929975 | chr7:136962660-136962661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs71533741 | chr7:136962665-136962666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565759978 | chr7:136962687-136962688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184782603 | chr7:136962765-136962766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570201376 | chr7:136962776-136962777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548137871 | chr7:136962781-136962782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535590936 | chr7:136962825-136962826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555789927 | chr7:136962837-136962838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34193196 | chr7:136962843-136962844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574688477 | chr7:136962881-136962882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373443570 | chr7:136962926-136962927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550797040 | chr7:136962927-136962928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs376640805 | chr7:136962947-136962948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570704304 | chr7:136962981-136962982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113765822 | chr7:136963009-136963010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs71533742 | chr7:136963026-136963027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369656351 | chr7:136963041-136963042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs367592579 | chr7:136963054-136963055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs71176391 | chr7:136963078-136963079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201560202 | chr7:136963086-136963087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs833389 | chr7:136963115-136963116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs377593686 | chr7:136963151-136963152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558817432 | chr7:136963225-136963226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs61525640 | chr7:136963233-136963234 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Melanoma | 19188590 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Coffin-Siris syndrome | 21572526 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Low-grade fibromyxoid sarcoma | 21536545 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Neuroticism | 17667963 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:136938200-136980600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr7:136952200-136971000 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
3 | chr7:136961000-136962600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr7:136961200-136966000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr7:136961400-136962200 | Enhancers | Brain Anterior Caudate | brain |
6 | chr7:136961400-136965800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr7:136961400-136973600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
8 | chr7:136961400-136980600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr7:136961600-136962200 | Enhancers | Brain Cingulate Gyrus | brain |
10 | chr7:136961600-136962200 | Enhancers | Brain Substantia Nigra | brain |
11 | chr7:136961600-136967600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr7:136961600-136967800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
13 | chr7:136961800-136962200 | Weak transcription | Brain Hippocampus Middle | brain |
14 | chr7:136962000-136962400 | Weak transcription | Brain Angular Gyrus | brain |
15 | chr7:136962200-136962400 | Enhancers | Brain Hippocampus Middle | brain |
16 | chr7:136962200-136965600 | Weak transcription | Brain Substantia Nigra | brain |
17 | chr7:136962200-136966200 | Weak transcription | Brain Anterior Caudate | brain |
18 | chr7:136962200-136966200 | Weak transcription | Brain Cingulate Gyrus | brain |
19 | chr7:136962400-136962600 | Enhancers | Brain Angular Gyrus | brain |
20 | chr7:136962400-136965800 | Weak transcription | Brain Hippocampus Middle | brain |
21 | chr7:136962600-136964200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
22 | chr7:136962600-136965000 | Weak transcription | Brain Angular Gyrus | brain |